Search - tctmd.com

Displaying 1 - 4 of 4

Sort: Relevancy | Date

News Daily News

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Michael O'Riordan

March 09, 2016

News Daily News

FDA 与阿玛琳之间的和解是否会减弱该局对标签外用途推广的监督？

Michael O'Riordan

March 09, 2016

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

September 14, 2011

News Conference News

PROTECTION-AMI: Experimental Agent Does Not Prevent Reperfusion Injury

April 05, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.